Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Angiopoietin-like 3 Messenger RNA (ANGPTL3 mRNA)
- Target
- ANGPTL3 mRNA
- Molecular classification
- mRNA, Precursor molecule
01
Overview
Angiopoietin-like 3 messenger RNA (ANGPTL3 mRNA) is the template for the synthesis of ANGPTL3 protein, a key regulator of lipid metabolism. ANGPTL3 inhibits lipoprotein lipase (LPL) and endothelial lipase (EL), influencing plasma levels of triglycerides, LDL cholesterol, and HDL cholesterol. Targeting ANGPTL3 mRNA with RNA interference is a promising therapeutic strategy for managing dyslipidemia.
- Other names
- ANGPTL3 mRNAAngiopoietin-like protein 3 mRNA
02
Mechanism of action
mRNA degradation via RNA interference, preventing ANGPTL3 protein synthesis
03
Biological functions
Template for protein synthesisRegulation of lipid metabolismInhibition of lipoprotein lipase (LPL)Inhibition of endothelial lipase (EL)
04
Disease associations
DyslipidemiaHypercholesterolemiaHypertriglyceridemiaCardiovascular disease
05
Safety considerations
Potential off-target effects of RNA interference therapeuticsUnintended consequences of long-term ANGPTL3 inhibition
06
Interacting drugs
RNA interference therapeutics (siRNA, antisense oligonucleotides)
1 more in the full profile.
07
Biomarkers
ANGPTL3 mRNA levelsANGPTL3 protein levelsLDL-C levelsHDL-C levelsTriglyceride levels
Beyond the preview
Go deeper on Angiopoietin-like 3 Messenger RNA (ANGPTL3 mRNA).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Angiopoietin-like 3 Messenger RNA (ANGPTL3 mRNA).